AGMBAgomAb Therapeutics NV American Depositary Shares
13.25USDMkt Cap: 652.54M $P/E: —3d ago
AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases in the United States. The company's product pipeline includes Ontuni…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap652.54M $
Enterprise Value462.23M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-62.55M $
Revenue/Share—
Last Price13.25 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees62
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.74
PEG—
EV/EBITDA-7.05
EV/Revenue—
P/S—
P/B5.00
EPS (TTM)-1.58
EPS (Forward)-1.97
52W Range
13.0632% of range13.64
52W High13.64 USD
52W Low13.06 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-47.78%
ROA-40.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-51.74M $
CapEx (TTM)4.00K $
FCF Margin—
FCF Yield—
Net Debt-250.84M $
Net Debt/EBITDA3.83
Balance Sheet
Debt/Equity0.01
Current Ratio12.88
Quick Ratio12.55
Book Value/Sh2.650 USD
Cash/Share6.181 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)33.00 USD
Upside (mean)+149.1%
Target Range28.00 USD – 36.00 USD
$28.00+149.1% to mean$36.00
# Analysts5
Ownership
Shares Out.49.25M
Float11.45M
Insiders5.90%
Institutions53.63%
Short Interest
Short Ratio14.5d
Short % Float2.96%
Short % Out.2.45%
Shares Short1.20M
Short (prev mo.)1.24M
Technical
SMA 5012.80 (+3.5%)
SMA 20012.55 (+5.6%)
Beta—
S&P 52W Chg19.18%
Avg Vol (30d)68.22K
Avg Vol (10d)103.16K
Technical Indicators
RSI (14)48.9
MACD0.2436
MACD Signal0.3732
MACD Hist.-0.1296
BB Upper15.21 USD
BB Middle13.63 USD
BB Lower12.05 USD
BB Width23.16%
ATR (14)1.018 USD
Vol Ratio (20d)0.72x